Atlas Trials

A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma

Clinical trial NCT00415155 · WITHDRAWN

Trial details

NCT number
NCT00415155
Sponsor
Eli Lilly and Company
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2008-08-01
Primary completion
2011-01-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.